The advent of accurate, noninvasive angiography has raised hopes that
premorbid screening for cerebral aneurysm will soon be possible. This
article discusses the medical and economic issues which will determine
the appropriate conditions for, and cost-effectiveness of, large-scal
e aneurysm screening.